Reports for JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE

Brand name
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE

Company Name

JAMP PHARMA CORPORATION

Drug Identification Number

02418231

Ingredients & Strength

Anatomical Therapeutical Chemical (ATC) Code

  • C09DA
  • C09DA

Anatomical Therapeutical Chemical (ATC) Descriptor

  • ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
  • ANGIOTENSIN II ANTAGONISTS, COMBINATIONS

Status

CANCELLED POST MARKET
Shortage reports
Brand name Packaging size Status Date Created Date Updated Reports
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE 28 Resolved 2017-03-27 2017-09-27 4430
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE 100 Resolved 2017-03-27 2017-09-27 4441
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE 28 Actual shortage 2019-10-11 2026-03-17 96183
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE 100 Actual shortage 2019-10-11 2026-03-17 96192

Showing 1 to 4 of 4

Discontinuation reports
Brand name Packaging size Status Date Created Date Updated Reports

Showing 1 to 0 of 0